Key Takeaways
The PHQ-2 is a 2-question depression screening tool scored 0-6, using validated cutoff of ≥3 for positive screen
PHQ-2 screens for depressed mood and anhedonia over the past 2 weeks using a 4-point Likert scale
Positive PHQ-2 scores require PHQ-9 follow-up for diagnostic clarity; PHQ-2 alone cannot diagnose depression
Pabau’s digital forms and measurement-based care automation embed PHQ-2 screening into recurring patient workflows
Download Your Free PHQ-2 Template
PHQ-2 (Patient Health Questionnaire-2)
A ready-to-use screening form capturing depressed mood and anhedonia using 2 brief questions scored on a 4-point scale.
Download templateWhat is a PHQ-2 Template?
The PHQ-2 is a 2-item screening instrument that assesses the frequency of depressed mood and anhedonia (loss of interest or pleasure) over the past 2 weeks. It is the abbreviated entry-point for the larger Patient Health Questionnaire-9 (PHQ-9) suite. Clinically, the PHQ-2 template serves as a rapid depression screening tool in primary care, psychiatry, therapy, and wellness settings.
A PHQ-2 template is a structured intake or assessment form that clinicians use to capture these two screening questions in a standardized way. The questions are scored on a 4-point Likert scale (0 = Not at all, 3 = Nearly every day), producing a total score of 0-6. A score of 3 or higher indicates a positive screen requiring further evaluation with the full PHQ-9 or diagnostic interview.
Unlike diagnostic instruments, the PHQ-2 template functions as a gateway screening tool. It identifies patients who warrant deeper clinical assessment but does not establish a final diagnosis. This distinction is legally and clinically important: clinicians must never rely on the PHQ-2 alone to diagnose Major Depressive Disorder. Its role is triage and flagging.
How to Use a PHQ-2 Template
Administering a PHQ-2 template in your clinic involves five operational steps that fit naturally into existing intake and follow-up workflows:
- Administer during intake or routine appointment. Present the two questions in a quiet, private setting. Patients complete the form in the waiting area, clinic room, or via digital patient portal. Digital administration using digital forms reduces transcription errors and improves compliance.
- Score immediately. Sum responses to both questions. Total ranges 0-6. Scoring takes under 30 seconds and requires no calculation beyond addition.
- Interpret the score. A score of 0-2 indicates a negative screen; no further action required at this visit. A score of ≥3 is positive and triggers clinical follow-up.
- Route positive screens to PHQ-9 escalation. When a patient scores ≥3, administer the full 9-item PHQ-9 or arrange a structured clinical interview to assess depression severity and suicide risk. Document the routing decision in the clinical record.
- Schedule repeat screening for measurement-based care. For patients in active mental health treatment, repeat the PHQ-2 at each session or monthly to monitor symptom trajectory. Pabau’s measurement-based care workflows automate recurring PHQ-2 administration and track trends over time.
Who is the PHQ-2 Helpful For?
The PHQ-2 template is beneficial across multiple healthcare settings and professional roles:
- Primary care clinics: General practitioners and nurse practitioners use PHQ-2 to screen all new adult patients, identifying undetected depression before complications arise.
- Mental health practices: Psychiatrists, therapists, counselors, and psychology practices use PHQ-2 as a session-by-session outcome measure to track treatment progress.
- Wellness and functional medicine clinics: Practitioners assess mood as part of comprehensive preventive health, especially when lifestyle interventions or supplement protocols address mood symptoms.
- Occupational and physical therapy: Therapists screen for depression that may limit engagement in rehabilitation or recovery protocols.
- Integrated care and telehealth providers: Remote practitioners can administer PHQ-2 via client portal before or after sessions, maintaining asynchronous clinical workflows.
Benefits of Using a PHQ-2 Template
Efficiency and standardization: A printed or digital PHQ-2 template ensures every patient is screened consistently, reducing the chance that depression goes undetected due to clinician oversight or time pressure.
Rapid administration: Two questions take 1-2 minutes to complete, fitting easily into even high-volume clinic schedules. This brevity increases compliance: patients are more willing to complete a 2-item form than a 9-item survey.
Objective documentation: A template with scored responses creates a permanent clinical record. This supports audit trails, patient compliance tracking, and regulatory compliance (CQC, HIPAA, GDPR). Templates also reduce transcription errors compared to clinician recall.
Clinical safety and escalation: Structured routing from PHQ-2 to PHQ-9 on positive screens reduces the risk of missed depression diagnoses. Clear cutoff scores (≥3) leave no ambiguity about when escalation is needed.
PHQ-2 Questions and Scoring Guide
The two PHQ-2 questions are:
- Over the past 2 weeks, how often have you been bothered by feeling down, depressed, or hopeless? (0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day)
- Over the past 2 weeks, how often have you been bothered by little interest or pleasure in doing things? (0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day)
Each patient rates both on the 4-point Likert scale. Total score = sum of both responses. Interpretation: 0-2 = negative screen (low depression risk); ≥3 = positive screen (depression likely, further evaluation needed).
The validated cutoff score of 3 was established by Kroenke, Spitzer, and Williams in their original validation study (published in Medical Care, 2003). This threshold balances sensitivity (catching true cases) with specificity (minimizing false positives).
PHQ-2 vs PHQ-9: When to Use Each
A common clinical question: should I use PHQ-2 or PHQ-9? The answer depends on your workflow stage.
Use PHQ-2 for: Initial screening in busy or high-volume settings. Deploy at every intake or annual checkup when efficiency is critical. PHQ-2 requires 1-2 minutes and identifies the subset of patients needing deeper assessment.
Use PHQ-9 for: Confirmed or suspected depression. When PHQ-2 is positive (score ≥3), administer PHQ-9 to measure symptom severity across nine domains (mood, anhedonia, sleep, energy, appetite, guilt, concentration, psychomotor changes, suicidal ideation). The PHQ-9 total score (0-27) also tracks treatment response at follow-up sessions.
In practice, many clinics use both: PHQ-2 as a universal screening gate, then PHQ-9 for all positive screens and ongoing measurement-based care during treatment. Digital systems can automate this routing, triggering psychiatric evaluation workflows when thresholds are crossed.
PHQ-2 in Measurement-Based Care Workflows
The true clinical power of a PHQ-2 template emerges in measurement-based care (MBC) protocols. Rather than administering PHQ-2 once at intake, clinics using MBC administer it repeatedly-at every session or monthly-to track mood trajectory quantitatively.
This approach has strong evidence: NIH Common Data Elements endorse PHQ-2 as a standard outcome measure. Clinicians graph scores over time, identifying which patients respond to therapy or medication and which require treatment adjustments.
MBC workflow example: A psychotherapy clinic gives every client a PHQ-2 at session start. Scores are entered into clinical workflows, graphed in the client record, and reviewed at supervision or treatment planning meetings. If a client’s PHQ-2 score plateaus or worsens despite 4 weeks of therapy, the clinician escalates to psychiatry for medication evaluation or intensive intervention.
Clinical Limitations and False Positives
A PHQ-2 template is a powerful screening tool but comes with important caveats.
No diagnostic certainty: A score ≥3 signals depression risk; it does not diagnose Major Depressive Disorder. DSM-5 diagnosis requires at least 5 of 9 symptoms for ≥2 weeks, plus functional impairment. The PHQ-2 captures only 2 of those 9 criteria. Always follow positive screens with the PHQ-9 or clinical interview.
False positives: Grief, situational sadness, medical illness, and medication side effects can mimic depressive symptoms and elevate PHQ-2 scores. Context matters. A patient scoring 3 after a death is not necessarily clinically depressed in the DSM sense.
Cultural sensitivity: PHQ-2 was validated in diverse populations but may miss presentations of depression that differ across cultures (e.g., somatic rather than affective symptoms in some cultural contexts).
Integrating PHQ-2 into Your Clinic’s EHR
Paper PHQ-2 templates work, but digital integration is more powerful. Modern psychiatry EHR software embeds PHQ-2 as a fillable form in the patient portal, with automatic scoring and clinical flagging.
When integrated with clinical documentation systems, PHQ-2 responses populate the patient record, create alerts for positive scores, and trigger automated reminders for PHQ-9 follow-up. Some systems generate client graphs over multiple visits, making trend analysis immediate.
PHQ-2 Billing and Coding Considerations
Depression screening using validated instruments is reimbursable in many settings. In the US, CPT code 96127 covers “Brief emotional/behavioral assessment (such as depression inventory or anxiety scale) administered by the physician or other qualified healthcare professional during an outpatient office visit or telehealth encounter.” Always verify coverage with your payer; coding rules vary by state and insurance type.
Conclusion
A PHQ-2 template is a evidence-based, rapid, and clinically validated tool for depression screening in any healthcare setting. Its brevity makes it practical for high-volume clinics; its validated cutoff (score ≥3) provides objective routing to further assessment; and its repeatability enables measurement-based care and outcome tracking.
Pabau’s clinical documentation and automated workflows embed PHQ-2 screening into digital intake and recurring patient assessments, reducing administrative friction and ensuring no patient falls through the cracks. Book a demo to see how PHQ-2 templates integrate into your clinic’s mental health workflows.
Frequently Asked Questions
The PHQ-2 is a rapid depression screening tool used to identify patients at risk of Major Depressive Disorder. A score of 3 or higher prompts further evaluation with the PHQ-9 or diagnostic interview. It is not designed to establish a final diagnosis or monitor depression severity alone.
A PHQ-2 score of 3 or higher is considered a positive screen. Scores of 0-2 indicate a negative screen. The cutoff of 3 was validated by the original authors (Kroenke, Spitzer, Williams) and balances sensitivity and specificity for depression detection.
PHQ-2 is a 2-item screener assessing depressed mood and anhedonia. PHQ-9 is the full 9-item depression severity measure covering mood, anhedonia, sleep, energy, appetite, guilt, concentration, psychomotor changes, and suicidal ideation. Use PHQ-2 for rapid screening; use PHQ-9 for diagnostic assessment and severity tracking.
Sum the patient’s responses to both questions. Each response is scored 0-3 on a Likert scale. Total score ranges 0-6. A score of ≥3 is a positive screen; 0-2 is negative. Scoring takes less than 1 minute.
No. PHQ-2 is a screening tool only. It identifies patients who may have depression and need further evaluation. A positive PHQ-2 must always be followed by a full PHQ-9 assessment or clinical interview to establish a diagnosis and assess suicide risk.